Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-4-14
|
pubmed:abstractText |
Type 1 insulin-dependent, diabetes mellitus (Type 1 DM) is thought to be more prevalent in individuals with Down's syndrome. To ascertain the local prevalence of Type 1 DM in patients with Down's syndrome in a geographically defined area, the four diabetes clinics in Lothian were surveyed and 13 patients with Down's syndrome and Type 1 DM were identified. Using data from previous epidemiological surveys which determined the prevalence of Down's syndrome in the general population, the prevalence rate of Type 1 DM in patients with Down's syndrome was calculated to be between 1.4 and 10.6%, a prevalence considerably higher than in the general population. Although 7 (54%) of the Down's syndrome patients were treated with once daily administration of insulin, the mean HbA1c value of the group was similar to that observed in a control group of 39 age-, sex- and duration-matched Type 1 patients, all of whom were taking two or more injections of insulin daily. Glycaemic control was therefore of similar quality to matched Type 1 patients without Down's syndrome, despite the frequent use of simple insulin regimens, which may relate to the more stable lifestyle of these patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0742-3071
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
160-3
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9507919-Adult,
pubmed-meshheading:9507919-Age of Onset,
pubmed-meshheading:9507919-Blood Pressure,
pubmed-meshheading:9507919-Cholesterol,
pubmed-meshheading:9507919-Diabetes Mellitus, Type 1,
pubmed-meshheading:9507919-Down Syndrome,
pubmed-meshheading:9507919-Female,
pubmed-meshheading:9507919-Hemoglobin A, Glycosylated,
pubmed-meshheading:9507919-Humans,
pubmed-meshheading:9507919-Hypoglycemic Agents,
pubmed-meshheading:9507919-Insulin,
pubmed-meshheading:9507919-Male,
pubmed-meshheading:9507919-Middle Aged,
pubmed-meshheading:9507919-Prevalence,
pubmed-meshheading:9507919-Scotland,
pubmed-meshheading:9507919-Triglycerides
|
pubmed:year |
1998
|
pubmed:articleTitle |
Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications.
|
pubmed:affiliation |
Department of Diabetes, Royal Infirmary of Edinburgh, NHS Trust, UK.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|